Difference between revisions of "Part:BBa K3610022:Design"

 
(→‎Source)
 
(3 intermediate revisions by the same user not shown)
Line 8: Line 8:
 
===Design Notes===
 
===Design Notes===
 
none
 
none
−
 
−
 
  
 
===Source===
 
===Source===
  
−
yeastgenome.org
+
Cyril Zipfel Lab at UZH, Switzerland
  
 
===References===
 
===References===
 +
Inobe T, Nukina N. Rapamycin-induced oligomer formation system of FRB-FKBP fusion proteins. J Biosci Bioeng. 2016;122(1):40-46. doi:10.1016/j.jbiosc.2015.12.004
 +
 +
Kolos, Jürgen M.; Voll, Andreas M.; Bauder, Michael; Hausch, Felix (2018): FKBP Ligands—Where We Are and Where to Go? In: Frontiers in Pharmacology 9, S. 1425. DOI: 10.3389/fphar.2018.01425.

Latest revision as of 23:12, 27 October 2020


FKBP


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

none

Source

Cyril Zipfel Lab at UZH, Switzerland

References

Inobe T, Nukina N. Rapamycin-induced oligomer formation system of FRB-FKBP fusion proteins. J Biosci Bioeng. 2016;122(1):40-46. doi:10.1016/j.jbiosc.2015.12.004

Kolos, Jürgen M.; Voll, Andreas M.; Bauder, Michael; Hausch, Felix (2018): FKBP Ligands—Where We Are and Where to Go? In: Frontiers in Pharmacology 9, S. 1425. DOI: 10.3389/fphar.2018.01425.